Grant: Project Grant
University of Alberta
$918,000.00
Understanding Pulmonary Neuroendocrine Cells as Allergen Sensors and Immune Modulators
FY 2024-25
Summary
This study focuses on specialized cells in the lung called Pulmonary Neuroendocrine Cells (PNEC). PNEC are found in the surface lining of the lung (epithelium) and are very rare (less than 1% of cells in the epithelium) but play an important role in detecting changes in the content of the air we breathe (oxygen levels, pollutants, bacteria), allowing the lungs to respond and maintain healthy function. PNEC are increased in number in asthmatics and recent studies, in mice, suggest that these cells play a key role in causing asthma and/or making asthma symptoms worse. However, very little is known about the function of human PNEC and how they contribute to asthma. We have established a novel method to culture human PNEC; allowing us to study the biology of a cell that is too rare to isolate from human lung tissue. Our own preliminary work shows that, when exposed to House Dust Mite (HDM), an inflammatory trigger in many asthmatics, PNEC start expressing Calcitonin Gene Related Peptide (CGRP), a neuropeptide known to enhance airway inflammation. In this study we will use our model of human PNEC to better understand how these cells respond to a range of common asthma triggers and how cells from asthmatics differ in their response to those from healthy individuals. We will also investigate how PNEC communicate with and alter the function of immune cells that play an important role in asthma. With successful completion of this project, we will gain an important understanding of PNEC and the role of this cell in Asthma. This knowledge may then be harnessed to develop entirely new approaches to asthma therapy with the possibility of reducing disease burden in those who do not respond to current treatments.
Department
Program
Project Grant
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
508480
Name
Forsythe Paul
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Respiratory System
Projecttitle
Understanding Pulmonary Neuroendocrine Cells as Allergen Sensors and Immune Modulators
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$918,000
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Airway Epithelium; Allergy; Asthma; Metabolomics; Neuroendocrine; Neuropeptides; Neurotransmitters
Abstract
This study focuses on specialized cells in the lung called Pulmonary Neuroendocrine Cells (PNEC). PNEC are found in the surface lining of the lung (epithelium) and are very rare (less than 1% of cells in the epithelium) but play an important role in detecting changes in the content of the air we breathe (oxygen levels, pollutants, bacteria), allowing the lungs to respond and maintain healthy function. PNEC are increased in number in asthmatics and recent studies, in mice, suggest that these cells play a key role in causing asthma and/or making asthma symptoms worse. However, very little is known about the function of human PNEC and how they contribute to asthma. We have established a novel method to culture human PNEC; allowing us to study the biology of a cell that is too rare to isolate from human lung tissue. Our own preliminary work shows that, when exposed to House Dust Mite (HDM), an inflammatory trigger in many asthmatics, PNEC start expressing Calcitonin Gene Related Peptide (CGRP), a neuropeptide known to enhance airway inflammation. In this study we will use our model of human PNEC to better understand how these cells respond to a range of common asthma triggers and how cells from asthmatics differ in their response to those from healthy individuals. We will also investigate how PNEC communicate with and alter the function of immune cells that play an important role in asthma. With successful completion of this project, we will gain an important understanding of PNEC and the role of this cell in Asthma. This knowledge may then be harnessed to develop entirely new approaches to asthma therapy with the possibility of reducing disease burden in those who do not respond to current treatments.
Competitiondate
202409
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Forsythe, Paul
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $918,000~ $0~